Rising Prevalence Of Gastrointestinal Disorders Drives Growth In Gastroretentive Drug Delivery Systems Outsourcing Market: A Key Driver Powering Gastroretentive Drug Delivery Systems Outsourcing Market Growth In 2025

The Gastroretentive Drug Delivery Systems Outsourcing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Gastroretentive Drug Delivery Systems Outsourcing Market Size and Its Estimated Growth Rate?
The gastroretentive drug delivery systems outsourcing market has shown strong growth in recent years. It will grow from $1.39 billion in 2024 to $1.5 billion in 2025, at a CAGR of 8.3%. This is due to the rising incidence of stomach and small intestine disorders and an increase in the number of hospitals.

The gastroretentive drug delivery systems outsourcing market is projected to grow robustly, reaching $2.03 billion by 2029 at a CAGR of 7.9%. This growth is supported by the rise of ambulatory centers, a focus on patient compliance and convenience, the increasing incidence of chronic diseases, personalized medicine, and the growing aging population. Key trends include advancements in polymer science, drug release technologies, bioadhesive systems, the development of gastroretentive dosage forms, and the integration of smart systems and digital health technologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15813

How Are Emerging Segments Shaping the Gastroretentive Drug Delivery Systems Outsourcing Market Landscape?
The gastroretentive drug delivery systems outsourcing market covered in this report is segmented -

1) By Type: Floating Systems, Bioadhesive Systems, Other Types
2) By Dosage Form: Tablets, Liquid, Microspheres, Capsule, Other Dosage Forms
3) By Application: Gastroesophageal Reflux Disease (GERD), Neurological Disorders, Other Applications
4) By End User: Pharmaceutical Companies, Contract Research Organizations (CROs), Other End Users

Subsegments:
1) Floating Systems: Single Unit Systems, Multiple Unit Systems
2) Bioadhesive Systems: Hydrogels, Mucoadhesive Polymers
3) Other Types: Magnetically Assisted Systems, High-Density Systems, Osmotic Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15813&type=smp

Which Growth Factors Are Influencing Gastroretentive Drug Delivery Systems Outsourcing Market Expansion?
The rising cases of gastrointestinal diseases are projected to expand the gastroretentive drug delivery systems outsourcing market. Gastrointestinal disorders impact the digestive system, including organs like the stomach, liver, intestines, and pancreas. Their increase is attributed to aging, stress, dietary shifts, antibiotic use, infections, and obesity. Outsourcing gastroretentive drug delivery enables pharmaceutical companies to better address this healTH*Care burden, improving treatment access and patient outcomes. For instance, in January 2023, the American Cancer Society reported that gastrointestinal cancer cases in the US rose by 3.18%, from 338,090 in 2021 to 348,840 in 2022. Therefore, the increasing incidence of gastrointestinal conditions is advancing the gastroretentive drug delivery systems outsourcing market.

Who Are the Dominant Players Across Different Gastroretentive Drug Delivery Systems Outsourcing Market Segments?
Major companies operating in the gastroretentive drug delivery systems outsourcing market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Evonik Industries AG, Alcon Inc., SGS SA, Lonza Group AG, FMC Corporation, Sun Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup Inc., Cadila Pharmaceuticals, Ashland Global Holdings Inc., Lupin Limited, Torrent Pharmaceuticals Ltd., Evotec SE, Colorcon Inc., Ranbaxy Laboratories Limited, Quotient Sciences Limited, Aenova Group, Vectura Group Ltd., Assertio Therapeutics Inc., Coating Place Inc., Xiromed LLC, SPI Pharma Inc.

What Are the Major Trends Shaping the Gastroretentive Drug Delivery Systems Outsourcing Market?
Leading enterprises in the gastroretentive drug delivery systems outsourcing market are honing their focus on creating pioneering products like ready-to-fill (RTF) colon functional capsules to boost drug delivery efficacy and patient comfort. This refers to ready-made, unfilled capsules, specifically created to be packed with specific drugs or active components intended for the colon. As an illustration, Evonik, a proficient drug delivery organization from Germany, unveiled their EUDRACAP colon functional capsules in September 2024 for targeted oral drug delivery to the ileo-colonic area. These trailblazing capsules are the maiden ready-to-fill option in the market, with the aim of delivering delicate active components such as live biotherapeutic products (LBPs). Currently sold in technical grade, a GMP-grade variant is also under progression. EUDRACAP colon augments the oral drug development process by easing formulation and expediting market penetration, making it a significant leap in gastroretentive drug delivery systems.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastroretentive-drug-delivery-systems-outsourcing-global-market-report

Which Geographic Regions Are Expected to Dominate the Gastroretentive Drug Delivery Systems Outsourcing Market in the Coming Years?
North America was the largest region in the gastroretentive drug delivery systems outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastroretentive drug delivery systems outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastroretentive Drug Delivery Systems Outsourcing Market?
2. What is the CAGR expected in the Gastroretentive Drug Delivery Systems Outsourcing Market?
3. What Are the Key Innovations Transforming the Gastroretentive Drug Delivery Systems Outsourcing Industry?
4. Which Region Is Leading the Gastroretentive Drug Delivery Systems Outsourcing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.